Work

Excess Toxicity Associated with Docetaxel and Irinotecan in Patients with Metastatic, Gemcitabine-Refractory Pancreatic Cancer: Results of a Phase II Study

FWCI: 1.542
Cites: 24
Cited by: 24
Related to: 10